Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent Rehospitalizations
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT03764722
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT03764722
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland
- Registry status
- Unknown status
Technical summary
Registry record NCT03764722. Allocation not applicable; no masking; primary purpose treatment. Start 2018-08-01 (actual); primary completion 2021-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent Rehospitalizations
- Condition
- Systolic Heart Failure
- Intervention (Drug)
- Levosimendan
- Lead sponsor
- Collegium Medicum w Bydgoszczy
Record details
- Record id
cardio:ct-nct03764722- Content hash
3e74a41b080b7835413b6fd99bb2a8c18e85821b42b22f67e66d2ff3ae8e5adf